Table of Contents Table of Contents
Previous Page  76 / 78 Next Page
Information
Show Menu
Previous Page 76 / 78 Next Page
Page Background

74

NCCN Guidelines for Patients

®

Mycosis Fungoides, Version 1.2016

Index

biopsy

10–12, 14, 18, 20, 22

blood tests

12, 18–19, 22

chemotherapy

25–26, 28, 30, 32, 36, 40, 42–43,

47–48, 52–54

clinical trial

33–34, 36, 40–43, 47, 50–53, 59

complementary and alternative medicine

33

complete blood count

17, 18

comprehensive metabolic panel

17, 18

computed tomography

17, 19, 22

diagnosis

10–12, 18, 41, 43, 45, 47, 58, 62

electron beam therapy

29–30

immunohistochemistry

12

immunotherapy

27, 36, 45, 47, 53

lymphatic system

6–8, 14

lymphocyte

7, 8, 11, 14, 25

lymphoma

8, 11, 12, 14, 25–26, 36, 58

maintenance treatment

39

medical history

16, 17, 22

NCCN Member Institutions

73

NCCN panel members

72

pathology report

11, 58, 62

phototherapy

30, 36, 40–44, 46, 48, 50

physical exam

17

positron emission tomography/computed

tomography

17, 19, 22

retinoids

25, 36, 40, 42–44, 46, 48

stem cell transplant

32, 47, 51, 53–54

steroids

25, 36, 40–44, 46, 48

supportive care

31, 39

targeted therapy

53

Index